"Arsenicals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic or organic compounds that contain arsenic.
| Descriptor ID |
D001152
|
| MeSH Number(s) |
D01.075 D02.691.088
|
| Concept/Terms |
Arsenicals- Arsenicals
- Arsenic Compounds
- Compounds, Arsenic
|
Below are MeSH descriptors whose meaning is more general than "Arsenicals".
Below are MeSH descriptors whose meaning is more specific than "Arsenicals".
This graph shows the total number of publications written about "Arsenicals" by people in this website by year, and whether "Arsenicals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 2 | 2 | 4 |
| 2003 | 4 | 3 | 7 |
| 2004 | 5 | 2 | 7 |
| 2005 | 4 | 2 | 6 |
| 2006 | 3 | 1 | 4 |
| 2007 | 2 | 2 | 4 |
| 2008 | 4 | 4 | 8 |
| 2009 | 4 | 1 | 5 |
| 2010 | 2 | 2 | 4 |
| 2011 | 2 | 2 | 4 |
| 2012 | 1 | 3 | 4 |
| 2014 | 0 | 2 | 2 |
| 2015 | 2 | 1 | 3 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arsenicals" by people in Profiles.
-
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leuk Lymphoma. 2024 Mar; 65(3):378-382.
-
Arsenic exposure and prevalence of human papillomavirus in the US male population. Environ Sci Pollut Res Int. 2023 Jan; 30(1):1263-1275.
-
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leuk Lymphoma. 2022 03; 63(3):672-675.
-
Clinical Characteristics and Remedy Profiles of Patients with COVID-19: A Retrospective Cohort Study. Homeopathy. 2021 05; 110(2):86-93.
-
Serum homocysteine, arsenic methylation, and arsenic-induced skin lesion incidence in Bangladesh: A one-carbon metabolism candidate gene study. Environ Int. 2018 04; 113:133-142.
-
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017 03 09; 129(10):1275-1283.
-
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy. Cancer. 2016 Apr 15; 122(8):1160-8.
-
Time to abandon traditional chemotherapy for acute promyelocytic leukaemia? Lancet Oncol. 2015 Oct; 16(13):1274-5.
-
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide. Br J Haematol. 2015 Nov; 171(4):471-7.
-
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells. Blood. 2015 May 28; 125(22):3455-65.